24 May 2013
Keywords: astrazeneca, miss, target, crestor, filing, new, data
Article | 12 August 2002
AstraZeneca has said it expects to file additional data from ongoingstudies of its statin Crestor (rosuvastatin) with the US Food ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 August 2002
12 August 2002
23 May 2013
© 2013 thepharmaletter.com